Erratum

Erratum for the Research Article: “Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance” by W. Roh, P.-L. Chen, A. Reuben, C. N. Spencer, P. A. Prieto, J. P. Miller, V. Gopalakrishnan, F. Wang, Z. A. Cooper, S. M. Reddy, C. Gumbs, L. Little, Q. Chang, W.-S.Chen, K. Wani, M. P. De Macedo, E. Chen, J. L. Austin-Breneman, H. Jiang, J. Roszik, M. T. Tetzlaff, M. A. Davies, J. E. Gershenwald, H. Tawbi, A. J. Lazar, P. Hwu, W.-J. Hwu, A. Diab, I. C. Glitza, S. P. Patel, S. E. Woodman, R. N. Amaria, V. G. Prieto, J. Hu, P. Sharma, J. P. Allison, L. Chin, J. Zhang, J. A. Wargo, P. A. Futreal

+ See all authors and affiliations

Science Translational Medicine  12 Apr 2017:
Vol. 9, Issue 385, eaan3788
DOI: 10.1126/scitranslmed.aan3788

In the manuscript “Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance,” one tumor sample (40C) was inadvertently processed without a matched normal sample. Reanalysis following exclusion of this sample did not change conclusions of the paper nor statistical significance of analyses done. The individual sample was excluded prior to copy number analyses in the original analyses, and TCR clonality analyses were unaffected. These errors have been corrected in the PDF and HTML (full text) versions of the manuscript and in the Supplementary Materials. The authors apologize for the inconvenience.

Related Content

Navigate This Article